Cargando…

Differential expression of serum mir-363-3p in patients with polycystic ovary syndrome and its predictive value for their pregnancy

BACKGROUND: This study aimed to investigate the expression of serum miR-363-3p in patients with polycystic ovary syndrome (PCOS) and its predictive value for pregnancy after ovulation induction therapy. METHODS: The expression of serum miR-363-3p was detected by Reverse transcription quantitative po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sang, Min, Yu, Ying, Zhou, Zhi, Zhang, Yaqi, Chang, Haiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186668/ https://www.ncbi.nlm.nih.gov/pubmed/37189071 http://dx.doi.org/10.1186/s12905-023-02337-9

Ejemplares similares

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome
por: Stokkeland, Live Marie T, et al.
Publicado: (2021)

Correlation study on serum miR-222-3p and glucose and lipid metabolism in patients with polycystic ovary syndrome
por: Wang, Qin, et al.
Publicado: (2022)

SAT363 The Prevalence And Phenotype Of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population In Sub-Sahara Africa: The Nigeria-PEP Study
por: Makwe, Christian Chigozie, et al.
Publicado: (2023)

Evaluating the Differential Expression of miR-146a, miR-222, and miR-9 in Matched Serum and Follicular Fluid of Polycystic Ovary Syndrome Patients: Profiling and Predictive Value
por: Ashrafnezhad, Zhale, et al.
Publicado: (2022)

Tumor Suppressor Role of miR-363-3p in Gastric Cancer
por: Song, Bo, et al.
Publicado: (2015)

Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value
por: Song, Do Kyeong, et al.
Publicado: (2017)

363 Management of severe and critical COVID-19 in pregnancy
por: Trahan, Marie Julie, et al.
Publicado: (2021)

Pregnancy-related outcomes for women with polycystic ovary syndrome
por: McDonnell, Rose, et al.
Publicado: (2017)

Differential expression of microRNA in the serum of patients with polycystic ovary syndrome with insulin resistance
por: Huo, Yan, et al.
Publicado: (2022)

Value of ultrasonography parameters in diagnosing polycystic ovary syndrome
por: Gyliene, Augustina, et al.
Publicado: (2022)

Serum adiponectin in Indian women with polycystic ovary syndrome
por: Rajendra, Aishwarya, et al.
Publicado: (2023)

miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma
por: Wang, Yahong, et al.
Publicado: (2017)

Unravelling Polycystic Ovary Syndrome and Its Comorbidities
por: Kim, Kyung-Wook
Publicado: (2021)

miR-124-3p Combined with ANGPTL2 Has High Diagnostic Values for Obese and Nonobese Polycystic Ovary Syndrome
por: Dai, Hongmei, et al.
Publicado: (2022)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Differentiating Polycystic Ovary Syndrome from Adrenal Disorders
por: Yesiladali, Mert, et al.
Publicado: (2022)

Value of ultrasonography in the diagnosis of polycystic ovary syndrome – literature review
por: Bachanek, Michał, et al.
Publicado: (2015)

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome
por: Köninger, Angela, et al.
Publicado: (2014)

Relationship between serum cystatin C and polycystic ovary syndrome
por: Gozashti, Mohammad Hossein, et al.
Publicado: (2013)

Human Lin28 Forms a High-Affinity 1:1 Complex with the 106~363 Cluster miRNA miR-363
por: Peters, Daniel T., et al.
Publicado: (2016)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

miR-363-5p regulates endothelial cell properties and their communication with hematopoietic precursor cells
por: Costa, Ana, et al.
Publicado: (2013)

MiR‐363‐3p promotes prostate cancer tumor progression by targeting Dickkopf 3
por: Xu, Li‐zhe, et al.
Publicado: (2022)

Metformin serum concentrations during pregnancy and post partum – A clinical study in patients with polycystic ovary syndrome
por: Espnes, Ketil Arne, et al.
Publicado: (2022)

Differential expression of long non-coding RNA Regulator of reprogramming and its molecular mechanisms in polycystic ovary syndrome
por: Zhang, Zhihong, et al.
Publicado: (2021)

Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome
por: Yu, Ying, et al.
Publicado: (2021)

Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome
por: Xiang, Shou-Kui, et al.
Publicado: (2012)

Ovarian drilling in polycystic ovary syndrome: Long term pregnancy rate
por: Debras, E., et al.
Publicado: (2019)

Predictors of pregnancy after intrauterine insemination in women with polycystic ovary syndrome
por: Guan, Hui-Juan, et al.
Publicado: (2021)

Clinical management of pregnancy in women with polycystic ovary syndrome: An expert opinion
por: Bahri Khomami, Mahnaz, et al.
Publicado: (2022)

Polycystic ovary syndrome and recurrent pregnancy loss, a review of literature
por: Wartena, Rosa, et al.
Publicado: (2023)

MiR-185-5p Protects Against Angiogenesis in Polycystic Ovary Syndrome by Targeting VEGFA
por: Wei, Jingzan, et al.
Publicado: (2020)

Increased miR-188-3p in Ovarian Granulosa Cells of Patients with Polycystic Ovary Syndrome
por: Dai, Beibei, et al.
Publicado: (2021)

Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome*
por: Mardanian, Farahnaz, et al.
Publicado: (2011)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
por: Chang, Chia Lin, et al.
Publicado: (2019)

Serum retinol-binding protein 4 levels in polycystic ovary syndrome
por: Lingaiah, Shilpa, et al.
Publicado: (2019)

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome
por: Feng, Di, et al.
Publicado: (2019)

Hearty miR-363 controls HAND1 in cardiac cell specification
por: Gupta, Manoj K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_95bl3o4pj5sem3vc3irv92mbc6